Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.406 EUR
92.27 M EUR
2.64 B EUR
20.88 M
About SYNLAB AG INH O.N.
Sector
Industry
CEO
Mathieu Olivier Floreani
Website
Headquarters
Munich
Founded
2019
ISIN
DE000A2TSL71
FIGI
BBG00ZXRLRD9
Synlab AG engages in the provision of clinical laboratory and medical diagnostic services. The firm offers medical diagnostic information for patients, practicing doctors, clinics, and the pharmaceutical industry. It operates through the following geographical segments: France, Germany, South Region, and North and East Regions. The company was founded by Bartholomaeus Wimmer in 1998 and is headquartered in Munich, Germany.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on HAM exchange SYNLAB AG INH O.N. stocks are traded under the ticker SYAB.
SYAB reached its all-time high on Nov 22, 2021 with the price of 24.200 EUR, and its all-time low was 6.690 EUR and was reached on Mar 3, 2023. View more price dynamics on SYAB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track SYNLAB AG INH O.N. financials in yearly and quarterly reports right on TradingView.
SYNLAB AG INH O.N. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
SYAB net income for the last quarter is 24.98 M EUR, while the quarter before that showed −77.18 M EUR of net income which accounts for 132.36% change. Track more SYNLAB AG INH O.N. financial stats to get the full picture.
SYNLAB AG INH O.N. dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 2.91% and 48.52% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 27.05 K employees. See our rating of the largest employees — is SYNLAB AG INH O.N. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNLAB AG INH O.N. EBITDA is 428.23 M EUR, and current EBITDA margin is 15.61%. See more stats in SYNLAB AG INH O.N. financial statements.
Like other stocks, SYAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNLAB AG INH O.N. stock right from TradingView charts — choose your broker and connect to your account.